(-)-Eburnamonine
99%
- Product Code: 103214
CAS:
4880-88-0
| Molecular Weight: | 294.39 g./mol | Molecular Formula: | C₁₉H₂₂N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
(-)-Eburnamonine is primarily studied for its potential therapeutic applications in the field of medicine. It has shown promise in improving cognitive functions, particularly in conditions related to memory impairment and neurodegenerative diseases. Research suggests that it may enhance blood flow in the brain, which can be beneficial for patients suffering from cerebral insufficiency or age-related cognitive decline. Additionally, (-)-Eburnamonine has been explored for its vasodilatory effects, which could aid in treating circulatory disorders. Its neuroprotective properties are also of interest, as they may help in mitigating the effects of oxidative stress and neuronal damage. While further clinical studies are needed, these attributes highlight its potential as a valuable compound in neurological and vascular health.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £102.68 |
+
-
|
(-)-Eburnamonine
(-)-Eburnamonine is primarily studied for its potential therapeutic applications in the field of medicine. It has shown promise in improving cognitive functions, particularly in conditions related to memory impairment and neurodegenerative diseases. Research suggests that it may enhance blood flow in the brain, which can be beneficial for patients suffering from cerebral insufficiency or age-related cognitive decline. Additionally, (-)-Eburnamonine has been explored for its vasodilatory effects, which could aid in treating circulatory disorders. Its neuroprotective properties are also of interest, as they may help in mitigating the effects of oxidative stress and neuronal damage. While further clinical studies are needed, these attributes highlight its potential as a valuable compound in neurological and vascular health.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :